Lexicon Pharmaceuticals (NASDAQ:LXRX) Lifted to Sell at StockNews.com

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a research report issued on Thursday. Several other analysts have also commented on LXRX. Leerink Partnrs reiterated an “outperform” rating on shares of Lexicon Pharmaceuticals in a report on Tuesday, April 30th. Needham & Company LLC reissued a “hold” […]

Related Keywords

China ,Switzerland ,Swiss ,Leerink Partnrs ,Lexicon Pharmaceuticals Inc ,Principal Securities Inc ,Swiss National Bank ,China Universal Asset Management Co ,News Ratings For Lexicon Pharmaceuticals Daily ,Victory Capital Management Inc ,Institutional Investors Weigh In On Lexicon Pharmaceuticals ,Lexicon Pharmaceuticals Stock Down ,Lexicon Pharmaceuticals ,Needham Company ,Get Free Report ,Pharmaceuticals Stock Down ,National Bank ,Universal Asset Management ,Capital Management ,Principal Securities ,Lexicon Pharmaceuticals Daily ,